NTLA Q1 2026 Earnings: EPS Beat Amid No Revenue, Focus on Pipeline Progress - Profit Warning Alert
NTLA Q1 2026 Earnings: EPS Beat Amid No Revenue, Focus on Pipeline Progress - Profit Warning Alert careplusvn.com
Covered in this story
What has happened since
- Intellia Therapeutics Inc is up 6.7% since this was published, 89 days ago.
Price move measured from the close nearest publication to the latest quote.
Call it yourself
No calls on $NTLA yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Intellia Therapeutics Inc →Summary aggregated from careplusvn.com's public RSS feed. The full reporting belongs to careplusvn.com — please read it on their site.